IMCR - immunocore.com Price to Earnings Adjusted for Growth Rate

Corporate company logo of Immunocore Holdings plc (IMCR)

Flawless cold-chain transportation of medicines guarantees their efficacy, creating a foundation for stock growth. The PEG ratio demonstrates the market valuation of this process, where 0.00 reflects the latest value of the metric. The stability foundation is provided by the unique TCR technologies of the drug Kimmtrak and a team of elite immunologists whose professionalism protects the intellectual capital of Immunocore Holdings plc (IMCR).

IMCR: Immunocore PLC PEG Multiple 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for Immunocore Holdings (IMCR)

- market value and analyst target forecast:
Summary company analytics:IMCR Immunocore Corp
Original product of Immunocore

The stability of T-cell therapy supplies via contract partners directly impacts profit dynamics, which is reflected in the relationship between the P/E ratio and the growth rates of Immunocore Holdings plc (IMCR). This indicator compares the business's market value with its expansion: a value below one signals that the asset is undervalued, confirming the high efficiency of investments in scaling the innovative oncology drugs of Immunocore Holdings plc (IMCR).

Competitors of Immunocore Holdings plc

ImmunityBio, Inc. (IBRX) - Price to Net Income Growth Ratio|Janux Therapeutics Inc - Price/Earnings to Growth Multiple|Arcus Biosciences (RCUS) - Price to Earnings Adjusted for Growth Rate|ZYME: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio TNGX (Tango Therapeutics, Inc.)|IOVA: PEG Multiple|IMTX - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio xencor.com|Price/Earnings to Growth Multiple compasstherapeutics.com (CMPX)|Price/Earnings to Growth Ratio Replimune Group Inc (REPL)|Price/Earnings to Growth Multiple Lyell Immunopharma Inc LYEL|Innate Pharma SA - Price/Earnings to Growth Multiple|PEG Multiple Pyxis Oncology, Inc. PYXS|CGEN - Price/Earnings to Growth Ratio|IOBT (iobiotech.com) - Growth-Adjusted P/E Ratio|Sutro Biopharma, Inc (STRO) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate MiNK (INKT)|Price/Earnings to Growth Multiple HOWL|IMMX - Price to Net Income Growth Ratio|Price/Earnings to Growth Multiple ALXO (ALX Oncology Holdings)|CUE (Cue Biopharma) - Growth-Adjusted Payback Ratio|PEG Multiple PDSB (PDS Biotechnology)|Growth-Adjusted Payback Ratio SONN|MAIABiotech.com - PEG Multiple|Price to Earnings Adjusted for Growth Rate Liminatus|Lava Tx (LVTX) - Price/Earnings to Growth Ratio|NextCure, Inc. - Growth-Adjusted Payback Ratio|LPTX (Leap Tx) - PEG Multiple|PEG Multiple intensitytherapeutics.com|Price/Earnings to Growth Ratio senseibio.com (SNSE)|TOVX: Market Cap to Earnings and Growth Ratio|Gritstone bio - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income kinetabio.com (KA)|NEXI - Price/Earnings to Growth Ratio|Turnstone Biologics Corp - Company Value to Earnings Growth Ratio|VCNX: PEG Multiple|Harpoon Therapeutics Corp (HARP) - PEG Multiple